Barrington raised the firm’s price target on Merit Medical Systems to $96 from $95 and keeps an Outperform rating on the shares. The company reported a “strong” Q3 and its cash flow generation was “exceptional,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MMSI:
- Merit Medical price target lowered to $81 from $96 at Needham
- Merit Medical price target lowered to $88 from $92 at Piper Sandler
- Merit Medical price target raised to $76 from $70 at Canaccord
- Merit Medical raises FY23 EPS view to $2.93-$2.99 from $2.81-$2.92
- Merit Medical reports Q3 EPS 75c, consensus 65c
